[HTML][HTML] Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis
Y Dong, Z Xia, J Zhou, Y Hu, M Yue, Y Wang, M Hu - Thrombosis Journal, 2023 - Springer
Background Immune thrombocytopenia (ITP), which is a well-known hemorrhagic disorder
characterized by low platelet counts, has been shown to be associated with the risk of …
characterized by low platelet counts, has been shown to be associated with the risk of …
Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia
Background Functional platelet activation assays are required for the diagnosis of heparin-
induced thrombocytopenia (HIT). Due to their sophisticated methodology, they are only …
induced thrombocytopenia (HIT). Due to their sophisticated methodology, they are only …
[HTML][HTML] Treatment of Acute Ischaemic Stroke and Concomitant Multiple Arterial Splanchnic Thromboses in a Patient with Immune Thrombocytopenia on …
S Frol, J Pretnar Oblak, M Šabovič, P Kermer… - Neurology …, 2023 - mdpi.com
Immune thrombocytopenia (ITP) is an autoimmune blood disorder characterised by isolated
severe thrombocytopenia. Arterial thrombotic events, such as acute ischaemic stroke (AIS) …
severe thrombocytopenia. Arterial thrombotic events, such as acute ischaemic stroke (AIS) …
Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study
C Liang, Q Chen, Y Zhang - Therapeutic Advances in Drug …, 2024 - journals.sagepub.com
Background: Studies have shown conflicting results when using thrombopoietin-related
drugs (TPORD) for thromboembolic events (TEEs). Our study aimed to explore the …
drugs (TPORD) for thromboembolic events (TEEs). Our study aimed to explore the …